Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun Ding

Showing results (211-220 of 236) with videos related to

Pageof 24
Sort By:
NPJ Genomic Medicine|November 20, 2025
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancerDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
Nature Communications|June 13, 2018
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variantsTokhir Dadaev, Edward J Saunders, Paul J Newcombe, et al.
Breast Cancer Research : BCR|May 1, 2015
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriersSophie Blein, Claire Bardel, Vincent Danjean, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 22, 2012
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersFergus J Couch, Mia M Gaudet, Antonis C Antoniou, et al.
Nature Genetics|January 10, 2019
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociFredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, et al.
Nature Genetics|June 13, 2018
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociFredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, et al.
Plos Genetics|April 5, 2014
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersAna Osorio, Roger L Milne, Karoline Kuchenbaecker, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 16, 2020
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variantsDaniel R Barnes, Matti A Rookus, Lesley McGuffog, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 2014
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersPaolo Peterlongo, Jenny Chang-Claude, Kirsten B Moysich, et al.
Nature Communications|February 18, 2021
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriersJuliette Coignard, Michael Lush, Jonathan Beesley, et al.
Pageof 24

Showing results (211-220 of 236) with videos related to

Sort By:
Pageof 24
NPJ Genomic Medicine|November 20, 2025
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancerDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
Nature Communications|June 13, 2018
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variantsTokhir Dadaev, Edward J Saunders, Paul J Newcombe, et al.
Breast Cancer Research : BCR|May 1, 2015
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriersSophie Blein, Claire Bardel, Vincent Danjean, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 22, 2012
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersFergus J Couch, Mia M Gaudet, Antonis C Antoniou, et al.
Nature Genetics|January 10, 2019
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociFredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, et al.
Nature Genetics|June 13, 2018
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociFredrick R Schumacher, Ali Amin Al Olama, Sonja I Berndt, et al.
Plos Genetics|April 5, 2014
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersAna Osorio, Roger L Milne, Karoline Kuchenbaecker, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 16, 2020
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variantsDaniel R Barnes, Matti A Rookus, Lesley McGuffog, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 2014
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersPaolo Peterlongo, Jenny Chang-Claude, Kirsten B Moysich, et al.
Nature Communications|February 18, 2021
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriersJuliette Coignard, Michael Lush, Jonathan Beesley, et al.
Pageof 24